{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:06:31Z","timestamp":1790262391997,"version":"4.1.0"},"reference-count":69,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The induction of anergy in T cells, although widely accepted as critical for the maintenance of tolerance, is still poorly understood at the molecular level. Recent evidence demonstrates that in addition to blockade of costimulation using monoclonal antibodies (mAbs) directed against cell surface determinants, treatment of mixed lymphocyte reaction (MLR) cultures with interleukin 10 (IL-10) and transforming growth factor-\u03b2 (TGF-\u03b2) results in induction of tolerance, rendering alloreactive murine CD4+ T cells incapable of inducing graft-versus-host disease (GVHD) after in vivo transfer to histoincompatible recipients. The present study, using these cells prior to adoptive transfer, determined that IL-10\u2009+\u2009TGF-\u03b2\u2013tolerant CD4+ T cells exhibit an altered pattern of T-cell receptor (TCR) + CD28-mediated signaling and are incapable of progressing out of the G1 phase of the cell cycle during stimulation with HLA class II disparate antigen-presenting cells. TGF\u03b2 + IL-10\u2013tolerant cells were incapable of phosphorylating TCR-\u03b6, or activating ZAP-70, Ras, and MAPK, similarly to T-cell tolerized by blockade of B7\/CD28 and CD40\/CD40L pathways. Moreover, these cells were incapable of clonal expansion due to defective synthesis of cyclin D3 and cyclin A, and defective activation of cyclin-dependent kinase (cdk)4, cdk6, and cdk2. These cells also exhibited defective down-regulation of p27kip1 cdk inhibitor and lack of cyclin D2-cdk4 activation, Rb hyperphosphorylation, and progression to the S phase of the cell cycle. These data link anergy-specific proximal biochemical alterations and the downstream nuclear pathways that control T-cell expansion and provide a biochemical profile of IL-10\u2009+\u2009TGF-\u03b2\u2013tolerant alloreactive T cells that do not induce GVHD when transferred into MHC class II disparate recipients in vivo.<\/jats:p>","DOI":"10.1182\/blood.v97.2.565","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T08:46:47Z","timestamp":1027759607000},"page":"565-571","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":40,"title":["Altered T-cell receptor\u2009+\u2009CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-\u03b2\u2013treated alloreactive T cells that do not induce graft-versus-host disease"],"prefix":"10.1182","volume":"97","author":[{"given":"Vassiliki A.","family":"Boussiotis","sequence":"first","affiliation":[{"name":"From the Department of Adult Oncology, Dana-Farber Cancer Institute, Division of Medical Oncology, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, MA; Department of Pediatrics, Division of Bone Marrow Transplantation, University of Minnesota Cancer Center, Minneapolis, MN; SAIC Frederick and the Laboratory of Leukocyte Biology, MCI-FCRDC, Frederick, MD; Shering-Plough Research Institute, Kenilworth, NJ; and TIGET-H.S. RAFFAELE, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Ming","family":"Chen","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Dana-Farber Cancer Institute, Division of Medical Oncology, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, MA; Department of Pediatrics, Division of Bone Marrow Transplantation, University of Minnesota Cancer Center, Minneapolis, MN; SAIC Frederick and the Laboratory of Leukocyte Biology, MCI-FCRDC, Frederick, MD; Shering-Plough Research Institute, Kenilworth, NJ; and TIGET-H.S. RAFFAELE, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay C.","family":"Zeller","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Dana-Farber Cancer Institute, Division of Medical Oncology, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, MA; Department of Pediatrics, Division of Bone Marrow Transplantation, University of Minnesota Cancer Center, Minneapolis, MN; SAIC Frederick and the Laboratory of Leukocyte Biology, MCI-FCRDC, Frederick, MD; Shering-Plough Research Institute, Kenilworth, NJ; and TIGET-H.S. RAFFAELE, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Murphy","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Dana-Farber Cancer Institute, Division of Medical Oncology, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, MA; Department of Pediatrics, Division of Bone Marrow Transplantation, University of Minnesota Cancer Center, Minneapolis, MN; SAIC Frederick and the Laboratory of Leukocyte Biology, MCI-FCRDC, Frederick, MD; Shering-Plough Research Institute, Kenilworth, NJ; and TIGET-H.S. RAFFAELE, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Berezovskaya","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Dana-Farber Cancer Institute, Division of Medical Oncology, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, MA; Department of Pediatrics, Division of Bone Marrow Transplantation, University of Minnesota Cancer Center, Minneapolis, MN; SAIC Frederick and the Laboratory of Leukocyte Biology, MCI-FCRDC, Frederick, MD; Shering-Plough Research Institute, Kenilworth, NJ; and TIGET-H.S. RAFFAELE, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satwant","family":"Narula","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Dana-Farber Cancer Institute, Division of Medical Oncology, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, MA; Department of Pediatrics, Division of Bone Marrow Transplantation, University of Minnesota Cancer Center, Minneapolis, MN; SAIC Frederick and the Laboratory of Leukocyte Biology, MCI-FCRDC, Frederick, MD; Shering-Plough Research Institute, Kenilworth, NJ; and TIGET-H.S. RAFFAELE, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Roncarolo","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Dana-Farber Cancer Institute, Division of Medical Oncology, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, MA; Department of Pediatrics, Division of Bone Marrow Transplantation, University of Minnesota Cancer Center, Minneapolis, MN; SAIC Frederick and the Laboratory of Leukocyte Biology, MCI-FCRDC, Frederick, MD; Shering-Plough Research Institute, Kenilworth, NJ; and TIGET-H.S. RAFFAELE, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Dana-Farber Cancer Institute, Division of Medical Oncology, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, MA; Department of Pediatrics, Division of Bone Marrow Transplantation, University of Minnesota Cancer Center, Minneapolis, MN; SAIC Frederick and the Laboratory of Leukocyte Biology, MCI-FCRDC, Frederick, MD; Shering-Plough Research Institute, Kenilworth, NJ; and TIGET-H.S. RAFFAELE, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020012417184607200_B1","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood.V83.12.3815.3815","article-title":"In vivo blockade of CD28\/CTLA4: B7\/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice.","volume":"83","author":"Blazar","year":"1994","journal-title":"Blood."},{"key":"2020012417184607200_B2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.158.1.29","article-title":"Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.","volume":"158","author":"Blazar","year":"1997","journal-title":"J Immunol."},{"key":"2020012417184607200_B3","doi-asserted-by":"crossref","first-page":"8789","DOI":"10.1073\/pnas.94.16.8789","article-title":"CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.","volume":"94","author":"Kirk","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020012417184607200_B4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/381434a0","article-title":"Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.","volume":"381","author":"Larsen","year":"1996","journal-title":"Nature."},{"key":"2020012417184607200_B5","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJM199906033402202","article-title":"Transplantation of anergic histoincompatible bone marrow allografts.","volume":"340","author":"Guinan","year":"1999","journal-title":"N Engl J Med."},{"key":"2020012417184607200_B6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1084\/jem.184.1.19","article-title":"Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.","volume":"184","author":"Groux","year":"1996","journal-title":"J Exp Med."},{"key":"2020012417184607200_B7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T cell responses and prevents colitis.","volume":"389","author":"Groux","year":"1997","journal-title":"Nature."},{"key":"2020012417184607200_B8","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.4049\/jimmunol.150.11.4754","article-title":"Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.","volume":"150","author":"de Waal Malefyt","year":"1993","journal-title":"J Immunol."},{"key":"2020012417184607200_B9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.174.4.915","article-title":"Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation via downregulation of class II major histocompatibility complex.","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J Exp Med."},{"key":"2020012417184607200_B10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4049\/jimmunol.151.3.1224","article-title":"IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.","volume":"151","author":"Ding","year":"1993","journal-title":"J Immunol."},{"key":"2020012417184607200_B11","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.4049\/jimmunol.151.5.2390","article-title":"Inhibition of Langerhans cell antigen-presenting function by IL-10. A role of IL-10 in induction of tolerance.","volume":"151","author":"Enk","year":"1993","journal-title":"J Immunol."},{"key":"2020012417184607200_B12","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.4049\/jimmunol.159.10.4772","article-title":"Induction of tolerance by IL-10-treated dendritic cells.","volume":"159","author":"Steinbrink","year":"1997","journal-title":"J Immunol."},{"key":"2020012417184607200_B13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/eji.1830240435","article-title":"Interleukin-10 inhibits B7 and intacellular adhesion molecule-1 expression on human monocytes.","volume":"24","author":"Willems","year":"1994","journal-title":"Eur J Immunol."},{"key":"2020012417184607200_B14","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.4049\/jimmunol.152.4.2011","article-title":"A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1 and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion.","volume":"152","author":"Gorczynski","year":"1994","journal-title":"J Immunol."},{"key":"2020012417184607200_B15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/00007890-199206000-00023","article-title":"Heart allografts in murine systems: the differential activation of Th2-like effector cells in peripheral tolerance.","volume":"53","author":"Takeuchi","year":"1992","journal-title":"Transplantation."},{"key":"2020012417184607200_B16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1084\/jem.179.2.493","article-title":"High levels of IL-10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.","volume":"179","author":"Bacchetta","year":"1994","journal-title":"J Exp Med."},{"key":"2020012417184607200_B17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/359693a0","article-title":"Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflamatory disease.","volume":"359","author":"Shull","year":"1992","journal-title":"Nature."},{"key":"2020012417184607200_B18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1074-7613(00)80170-3","article-title":"Abrogation of TGFb signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease.","volume":"12","author":"Gorelik","year":"2000","journal-title":"Immunity."},{"key":"2020012417184607200_B19","doi-asserted-by":"crossref","first-page":"12516","DOI":"10.1073\/pnas.95.21.12516","article-title":"Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor b1.","volume":"95","author":"Chen","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020012417184607200_B20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1172\/JCI3741","article-title":"CD4+ T cells tolerized ex-vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host lethality capacity but retain normal antigen responses.","volume":"102","author":"Blazar","year":"1998","journal-title":"J Clin Invest."},{"key":"2020012417184607200_B21","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.4049\/jimmunol.163.7.3684","article-title":"Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-\u03b2.","volume":"163","author":"Zeller","year":"1999","journal-title":"J Immunol."},{"key":"2020012417184607200_B22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.278.5335.124","article-title":"Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1.","volume":"278","author":"Boussiotis","year":"1997","journal-title":"Science."},{"key":"2020012417184607200_B23","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1128\/MCB.14.3.2066","article-title":"D-type cyclin-dependent kinase activity in mammalian cells.","volume":"14","author":"Matsushime","year":"1994","journal-title":"Mol Cell Biol."},{"key":"2020012417184607200_B24","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.271.5253.1272","article-title":"Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells.","volume":"271","author":"Li","year":"1996","journal-title":"Science."},{"key":"2020012417184607200_B25","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.271.5253.1276","article-title":"Blocked Ras activation in anergic CD4+ T cells.","volume":"271","author":"Fields","year":"1996","journal-title":"Science."},{"key":"2020012417184607200_B26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1073\/pnas.91.1.38","article-title":"Anergic T-lymphocyte clones have altered inositol phosphate, calcium and tyrosine kinase signaling pathways.","volume":"91","author":"Gajewski","year":"1994","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020012417184607200_B27","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/eji.1830250707","article-title":"Induction of the increased fyn kinase activity in anergic T helper type 1 clones requires calcium and protein synthesis and is sensitive to cyclosporin A.","volume":"25","author":"Gajewski","year":"1995","journal-title":"Eur J Immunol."},{"key":"2020012417184607200_B28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.184.2.365","article-title":"Differential association of protein tyrosine kinases with T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation.","volume":"184","author":"Boussiotis","year":"1996","journal-title":"J Exp Med."},{"key":"2020012417184607200_B29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1126\/science.7824949","article-title":"\u03b6 Phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists.","volume":"267","author":"Madrenas","year":"1995","journal-title":"Science."},{"key":"2020012417184607200_B30","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0092-8674(94)90080-9","article-title":"Partial T cell signaling: altered phospho-\u03b6 and lack of Zap70 recruitment in APL-induced T cell anergy.","volume":"79","author":"Sloan-Lancaster","year":"1994","journal-title":"Cell."},{"key":"2020012417184607200_B31","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.4049\/jimmunol.155.11.5083","article-title":"Defective TCR-mediated signaling in anergic T cells.","volume":"155","author":"Migita","year":"1995","journal-title":"J Immunol."},{"key":"2020012417184607200_B32","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1084\/jem.183.5.2017","article-title":"Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways.","volume":"183","author":"DeSilva","year":"1996","journal-title":"J Exp Med."},{"key":"2020012417184607200_B33","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1126\/science.281.5375.416","article-title":"Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development.","volume":"281","author":"Clements","year":"1998","journal-title":"Science."},{"key":"2020012417184607200_B34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.281.5375.413","article-title":"Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell.","volume":"28","author":"Yablonski","year":"1998","journal-title":"Science."},{"key":"2020012417184607200_B35","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/364352a0","article-title":"Direct interaction of Ras and the aminoterminal region of Raf-1 in vitro.","volume":"364","author":"Warne","year":"1993","journal-title":"Nature."},{"key":"2020012417184607200_B36","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1073\/pnas.90.18.8683","article-title":"GTP-dependent association of Raf-1 with Ha-Ras: identification of Raf as a target downstream of Ras in mammalian cells.","volume":"90","author":"Koide","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020012417184607200_B37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/364308a0","article-title":"Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.","volume":"364","author":"Zhang","year":"1993","journal-title":"Nature."},{"key":"2020012417184607200_B38","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.7811320","article-title":"Activation of Ras as a result of recruitment to the plasma membrane.","volume":"264","author":"Stokoe","year":"1994","journal-title":"Science."},{"key":"2020012417184607200_B39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/369411a0","article-title":"Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.","volume":"369","author":"Leevers","year":"1994","journal-title":"Nature."},{"key":"2020012417184607200_B40","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/j.1460-2075.1994.tb06361.x","article-title":"Activation of MEK family kinases requires phosphorylation of two conserved Ser\/Thr residues.","volume":"13","author":"Zheng","year":"1994","journal-title":"EMBO J."},{"key":"2020012417184607200_B41","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/j.1460-2075.1994.tb06424.x","article-title":"Identification of the sites in MAP kinase kinase-1 phosphorylated by p74 raf-1.","volume":"13","author":"Alessi","year":"1994","journal-title":"EMBO J."},{"key":"2020012417184607200_B42","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1084\/jem.180.3.1067","article-title":"The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7\u20131, activates p21ras.","volume":"180","author":"Nunes","year":"1994","journal-title":"J Exp Med."},{"key":"2020012417184607200_B43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0167-5699(95)80134-0","article-title":"The regulation and function of p21ras during T-cell activation and growth.","volume":"16","author":"Izquierdo","year":"1995","journal-title":"Immunol Today."},{"key":"2020012417184607200_B44","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1016\/S0021-9258(18)53587-0","article-title":"Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes.","volume":"268","author":"Ajchenbaum","year":"1993","journal-title":"J Biol Chem."},{"key":"2020012417184607200_B45","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1128\/MCB.14.3.2077","article-title":"Identification of G1 kinase activity for cdk6, a novel cyclin D partner.","volume":"14","author":"Meyerson","year":"1994","journal-title":"Mol Cell Biol."},{"key":"2020012417184607200_B46","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.4049\/jimmunol.158.12.5642","article-title":"The regulation of p27kip1 expression following the polyclonal activation of murine Go T cells.","volume":"158","author":"Kwon","year":"1997","journal-title":"J Immunol."},{"key":"2020012417184607200_B47","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1101\/gad.8.15.1759","article-title":"Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein.","volume":"1994","author":"Hatakeyama","year":"1994","journal-title":"Genes Dev."},{"key":"2020012417184607200_B48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/cdk4.","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature."},{"key":"2020012417184607200_B49","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/366701a0","article-title":"p21 is a universal inhibitor of cyclin kinases.","volume":"366","author":"Xiong","year":"1993","journal-title":"Nature."},{"key":"2020012417184607200_B50","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.","volume":"75","author":"Harper","year":"1993","journal-title":"Cell."},{"key":"2020012417184607200_B51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1101\/gad.8.1.9","article-title":"p27kip1 a cyclin-cdk inhibitor, links transforming factor-beta and contact inhibition to cell cycle arrest.","volume":"8","author":"Polyak","year":"1994","journal-title":"Genes Dev."},{"key":"2020012417184607200_B52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0092-8674(94)90573-8","article-title":"p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity is related to p21.","volume":"78","author":"Toyoshima","year":"1994","journal-title":"Cell."},{"key":"2020012417184607200_B53","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1101\/gad.9.10.1149","article-title":"Inhibitors of mammalian G1 cyclin-dependent kinases.","volume":"9","author":"Sherr","year":"1995","journal-title":"Genes Dev."},{"key":"2020012417184607200_B54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/73144","article-title":"p27kip1 functions as an anergy factor inhibiting IL-2 transcription and clonal expansion of alloreactive human and murine helper T lymphocytes.","volume":"6","author":"Boussiotis","year":"2000","journal-title":"Nat Med."},{"key":"2020012417184607200_B55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1084\/jem.184.2.407","article-title":"Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.","volume":"184","author":"Solvason","year":"1996","journal-title":"J Exp Med."},{"key":"2020012417184607200_B56","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1073\/pnas.91.18.8655","article-title":"cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase and holoenzyme.","volume":"91","author":"Flores-Rozas","year":"1994","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020012417184607200_B57","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/369574a0","article-title":"The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.","volume":"369","author":"Waga","year":"1994","journal-title":"Nature."},{"key":"2020012417184607200_B58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/375159a0","article-title":"Cell-cycle inhibition by independent CDK and PCNA binding domains in p21 Cip1.","volume":"375","author":"Luo","year":"1995","journal-title":"Nature."},{"key":"2020012417184607200_B59","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0966-3274(96)80015-3","article-title":"TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells.","volume":"4","author":"Bonham","year":"1996","journal-title":"Transpl Immunol."},{"key":"2020012417184607200_B60","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0092-8674(94)90540-1","article-title":"G1 phase progression: cyclin on cue.","volume":"79","author":"Sherr","year":"1994","journal-title":"Cell."},{"key":"2020012417184607200_B61","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.onc.1201228","article-title":"Induction of p27kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway.","volume":"15","author":"Kawada","year":"1997","journal-title":"Oncogene."},{"key":"2020012417184607200_B62","first-page":"5348","article-title":"Ras activity in G1 phase required for p27kip1 downregulation, passage through the restriction point and entry into S phase in growth factor-stimulated NIH-3T3 fibroblasts.","volume":"17","author":"Takuwa","year":"1997","journal-title":"Mol Cell Immunol."},{"key":"2020012417184607200_B63","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0092-8674(84)90531-2","article-title":"Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells.","volume":"38","author":"Feramisco","year":"1984","journal-title":"Cell."},{"key":"2020012417184607200_B64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/386177a0","article-title":"Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein.","volume":"386","author":"Peeper","year":"1997","journal-title":"Nature."},{"key":"2020012417184607200_B65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.184.1.1","article-title":"Models of T cell anergy: is there a common molecular mechanism?","volume":"184","author":"Schwartz","year":"1996","journal-title":"J Exp Med."},{"key":"2020012417184607200_B66","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1084\/jem.178.5.1753","article-title":"B7 but not ICAM-1 costimulation prevents the induction of human alloantigen specific tolerance.","volume":"178","author":"Boussiotis","year":"1993","journal-title":"J Exp Med."},{"key":"2020012417184607200_B67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1084\/jem.177.1.165","article-title":"Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7\/BB1.","volume":"177","author":"Tan","year":"1993","journal-title":"J Exp Med."},{"key":"2020012417184607200_B68","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199103073241005","article-title":"Mechanisms of disease. Graft-versus-host disease.","volume":"324","author":"Ferrara","year":"1991","journal-title":"N Engl J Med."},{"key":"2020012417184607200_B69","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/372570a0","article-title":"Interleukin-2-mediated elimination of the p27kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.","volume":"372","author":"Nourse","year":"1994","journal-title":"Nature."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/2\/565\/1590709\/565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/2\/565\/1590709\/565.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T16:10:30Z","timestamp":1682266230000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/97\/2\/565\/52857\/Altered-Tcell-receptorCD28mediated-signaling-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,15]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,1,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v97.2.565","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,1,15]]}}}